Quest Diagnostics is the world's leading provider of diagnostic testing, information, and services that patients and doctors need to make better healthcare decisions. The Company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its extensive medical and scientific staff, cancer diagnostics, and anatomic pathology services.

Quest Diagnostics's wide range of products and services benefit patients, healthcare providers, and pharmaceutical medical device companies, life insurance companies, and employers.

Type
Public
HQ
Madison, US
Size (employees)
43,000 (est)
Quest Diagnostics is headquartered in Madison, US
Report incorrect company information

Key People/Management at Quest Diagnostics

Stephen H. Rusckowski

Stephen H. Rusckowski

Chairman, President and Chief Executive Officer

Quest Diagnostics Office Locations

Quest Diagnostics has an office in Madison
Madison, US (HQ)
Giralda Farms
Show all (1)
Report incorrect company information

Quest Diagnostics Financials and Metrics

Quest Diagnostics Financials

Quest Diagnostics's revenue was reported to be $7.52 b in FY, 2016 which is a 0.3% increase from the previous period.
USD

Revenue (Q1, 2018)

1.9 b

Gross profit (Q1, 2018)

658 m

Gross profit margin (Q1, 2018), %

34.9%

Net income (Q1, 2018)

189 m

EBIT (Q1, 2018)

272 m

Market capitalization (15-May-2018)

13.9 b

Closing share price (15-May-2018)

102.1

Cash (31-Mar-2018)

124 m

EV

17.6 b
Quest Diagnostics's current market capitalization is $13.9 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

7.1 b7.4 b7.5 b7.5 b

Revenue growth, %

4%1%0%

Cost of goods sold

4.3 b4.6 b4.7 b4.6 b

Gross profit

2.8 b2.8 b2.8 b2.9 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Revenue

1.8 b1.7 b1.9 b1.9 b1.8 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b1.9 b

Cost of goods sold

1.1 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.1 b1.2 b1.2 b1.2 b1.2 b1.2 b1.2 b

Gross profit

698.6 m645 m728 m726 m676 m743 m718 m719 m751 m728 m734 m773 m741 m658 m

Gross profit Margin, %

39%37%38%38%37%39%38%39%39%39%39%40%38%35%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

187 m192 m133 m359 m

Inventories

91 m110 m84 m82 m

Current Assets

1.4 b1.6 b1.5 b1.5 b

PP&E

805 m933 m925 m1 b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Cash

158.3 m144 m144 m170 m974 m150 m123 m128 m283 m406 m367 m314 m350 m124 m

Inventories

85.2 m99 m109 m111 m106 m109 m86 m82 m80 m82 m77 m83 m100 m94 m

Current Assets

1.4 b1.5 b1.5 b1.6 b2.4 b1.5 b1.6 b1.5 b1.5 b1.6 b1.6 b1.5 b1.5 b1.4 b

PP&E

749.4 m851 m884 m888 m902 m906 m886 m925 m937 m952 m1 b1 b1.1 b1.2 b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

883 m592 m753 m696 m

Accounts Payable

(21 m)68 m(31 m)56 m

Cash From Operating Activities

652 m938 m810 m1.1 b

Cash From Investing Activities

328 m(1 b)(362 m)(152 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

732.1 m111 m253 m392 m70 m199 m553 m114 m324 m529 m175 m382 m557 m189 m

Depreciation and Amortization

211 m75 m156 m235 m78 m153 m230 m62 m123 m186 m62 m128 m197 m74 m

Accounts Payable

(76.8 m)(86 m)(39 m)20 m(120 m)(49 m)(41 m)(77 m)23 m43 m(95 m)(93 m)(3 m)(68 m)

Cash From Operating Activities

441.6 m84 m364 m635 m52 m327 m539 m143 m464 m765 m196 m490 m852 m180 m
USDY, 2018

EV/EBIT

64.7 x

EV/CFO

97.8 x

EV/FCF

164.5 x

Financial Leverage

2.1 x
Show all financial metrics

Quest Diagnostics Operating Metrics

FY, 2016

Accounts

250 k

Patents Issued

700

Patents Pending

570

Patient Service Centers

2.20 k
Show all operating metrics

Quest Diagnostics Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
California Laboratory Associates October 30, 2017
Cleveland HeartLab October 18, 2017
Cape Cod Healthcare - Business June 28, 2017
ClearPoint Diagnostic June 12, 2017
Med fusion June 12, 2017
PeaceHealth Laboratories February 15, 2017
Report incorrect company information

Quest Diagnostics News and Updates

Cellular Health Screening/Health Testing Global Market 2017: Key Players – Life Length, Repeat Diagnostics Inc, Titanovo, Cell Science Systems, Quest Diagnostics

Cellular Health Screening/Health Testing -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Esoteric Testing Market Qualitative Analysis by Manufacturers Quest Diagnostics, Myriad Genetics, Genomic Health

HTF MI published a new industry research that focuses on Esoteric Testing market and delivers in-depth market analysis and future prospects of Global Esoteric Testing market. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information